%0 Journal Article %A KRZYSZTOF CZYŻEWSKI %A ROBERT DĘBSKI %A NATALIA BARTOSZEWICZ %A EWA DEMIDOWICZ %A MONIKA RICHERT-PRZYGOŃSKA %A MONIKA ŁĘCKA %A SONIA TARASENKO %A JAN STYCZYŃSKI %T Impact of Palifermin on Transplant Outcomes in Children and Adolescents Undergoing Allogeneic Hematopoietic Cell Transplantation %D 2020 %R 10.21873/anticanres.14677 %J Anticancer Research %P 6531-6537 %V 40 %N 11 %X Background: Oral mucositis (OM) is considered to be one of the worst and most debilitating complications of conditioning for hematopoietic cell transplantation (HCT). Prevention and treatment of this complication is one of the utmost priorities of supportive therapy during transplant procedure. The objective of this study was the analysis of the influence of palifermin, keratinocyte growth factor (KGF), on transplant outcomes in patients undergoing allo-HCT. Patients and Methods: A total of 253 allo-HCTs performed between 2003-2018 in patients aged 0-19 years at a single center were analyzed. KGF was administered in 161 HCTs. Uni- and multivariate risk factor analyses were performed. Results: In spite of reducing the duration and grade of mucositis, no prognostic impact of KGF was shown for overall survival, event-free survival, relapse incidence, acute and chronic graft-versus-host disease (GVHD), nor GVHD-free relapse-free survival. Conclusion: Palifermin had no impact on transplant outcomes in children and adolescents undergoing allo-HCT. %U https://ar.iiarjournals.org/content/anticanres/40/11/6531.full.pdf